ESCO Technologies Inc. — FY2022 Form 10-K
Business context and reporting period. This annual report covers the fiscal year ended September 30, 2022; it does not provide a standalone fourth-quarter summary. ESCO operates in Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Shielding and Test (Test), serving aerospace, defense, electric utilities, renewables, and testing markets. The company’s reported results are from continuing operations; Technical Packaging was sold in 2019 and is presented as discontinued operations.
Financial performance
| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Net sales | $857.5 million | $715.4 million | +19.9% |
| Net earnings | $82.3 million | $63.5 million | +29.6% |
| Diluted EPS, GAAP | $3.16 | $2.42 | +$0.74 |
| EBIT | $111.3 million | $82.9 million | +34.3% |
| EBIT margin | 13.0% | 11.6% | +1.4 percentage points |
| Operating cash flow | $135.3 million | $123.1 million | +$12.1 million |
Gross margin, calculated from reported net sales and cost of sales, was approximately 38.7%, versus 37.8% in FY2021. SG&A was $195.1 million, or 22.7% of sales, compared with $167.5 million, or 23.4%. Net interest expense rose to $4.9 million from $2.3 million. The effective tax rate increased to 22.7% from 21.3%.
Sales by segment: A&D revenue was $351.4 million (+11.6%); USG was $278.4 million (+37.2%); and Test was $227.7 million (+15.2%). Management attributed approximately $90 million of growth to organic sales and approximately $52 million to acquisitions. USG’s increase included $46.9 million from the 2021 Phenix and Altanova acquisitions.
Liquidity, debt, and capital allocation
- Cash and cash equivalents were $97.7 million; total borrowings were $153.0 million, resulting in net debt of approximately $55.3 million.
- Working capital was $254.5 million, up from $191.2 million. Current assets were $572.6 million and current liabilities $318.1 million.
- Approximately $339 million was available under the $500 million revolving credit facility. The facility matures September 27, 2024; the company reported compliance with its covenants.
- Investing cash outflow was $55.9 million, down from $202.4 million, mainly because acquisition spending fell. Capital expenditures were $32.1 million and capitalized software spending was $12.9 million.
- The company paid $8.3 million in dividends ($0.32 per share) and repurchased approximately 257,500 shares for $20.0 million.
Material changes, outlook, and risks
- Orders were $960.5 million, a 1.12x book-to-bill ratio. Backlog rose 17.4% to $695.0 million; approximately 80% was expected to be completed in FY2023. This is backlog conversion commentary, not formal earnings guidance.
- Management described the financial position and liquidity as strong and said operating cash flow and credit-facility borrowings should support capital and operating needs. The filing provides no clear quantified FY2023 revenue or earnings guidance.
- Growth reflected the recovery in commercial aerospace, higher utility and renewable-energy demand, and acquired businesses. Price increases and sales volume supported segment EBIT, while inflation, materials costs, and higher travel and event spending were offsets.
- Key risks include supply-chain constraints and inflation; reliance on sole- or limited-source suppliers; U.S. government funding and contract termination; economic weakness, higher interest rates, tariffs, foreign-exchange movements, and geopolitical conflict; cybersecurity and product-liability exposures; and uncertainty in acquisition integration and long-term contract cost estimates.
- Management reported no goodwill or long-lived-asset impairment in FY2022. Litigation and environmental matters were described as adequately accrued, insured, or not expected to materially affect results, although outcomes and cleanup costs remain uncertain. Long-term contract estimate adjustments reduced pretax earnings by $0.9 million, or diluted EPS by $0.03.
- FY2022 adjusted diluted EPS was $3.21 versus $2.59 in FY2021, excluding specified acquisition, purchase-accounting, severance, restructuring, and other items. This non-GAAP measure should be considered alongside GAAP EPS.
Important facts for investors to verify
- Review the audited financial statements and credit-facility note for debt terms, interest-rate exposure, covenant headroom, and the planned repayment of $20 million classified as current.
- Assess whether the $695.0 million backlog converts as expected, particularly government-related orders and contracts subject to termination or modification.
- Separate organic growth from acquisition contributions and evaluate the ongoing costs, amortization, and integration performance of Altanova, Phenix, and NEco.
- Monitor inflation, supplier concentration, inventory and contract-asset growth, and the sensitivity of long-term contract margins to revised cost estimates.
- Compare GAAP results with management’s adjusted EPS reconciliation. The filing reports unqualified audit opinions and effective internal controls over financial reporting as of September 30, 2022.